Jason Franasiak, MD, FACOG, HCLD/ALD (ABB)

Chief Medical Officer of IVIRMA America

RMA New Jersey

Jason Franasiak, MD, FACOG, HCLD/ALD (ABB)

Biografía

Dr. Jason Franasiak, MD, FACOG, HCLD/ALD (ABB) is an attending physician at Reproductive Medicine Associates of New Jersey where he serves as lead physician of the South Jersey Marlton office, Assistant Professor at Thomas Jefferson University in the Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, and Chief Medical Officer of IVI-RMA America. He graduated from The College of William & Mary with focus in Biology and Biochemistry and at graduation was awarded the James Frederic Carr Memorial Cup for the single graduate who best represents “character, leadership, and scholarship.”

He went on to pursue medicine at the University of Virginia where he received his medical degree and was awarded the Shannon Z. Award for the “most well-rounded” medical student and the Algernon Sydney Sullivan Award recognizing the person from both the undergraduate and graduate schools who exhibited “excellence of character and service to humanity.” He completed his residency training in Obstetrics and Gynecology at the University of North Caroline at Chapel Hill where he was elected Education Administrative Chief Resident. Dr. Franasiak completed his Reproductive Endocrinology and Infertility fellowship training at Reproductive Medicine Associates of New Jersey (RMANJ) in the Rutgers Robert Wood Johnson fellowship program.

Dr. Franasiak is a board certified Obstetrician Gynecologist, board certified Technical Supervisor in Embryology and Andrology. He is active in the American College of Obstetrician and Gynecologists (ACOG) on the Practice Bulletin Committee for Gynecology. He also serves the American Society for Reproductive Medicine (ASRM) and has been on the executive board of the Society for Reproductive Endocrinology and Infertility (SREI). He volunteers as an OB/GYN Clinical Advisor for Osmosis – Integrated Medical Learning and works with Kaplan Test Prep for USMLE Step, 1, 2, and 3 reproductive medicine coursework.
Dr. Franasiak has been invited to speak nationally and internationally and has authored and contributed to over 100 peer reviewed publications, published chapters and abstracts. He serves on the Editorial Board for Fertility and Sterility and the British Journal of Obstetrics and Gynecology. He also serves as Ad Hoc Reviewer for the Journal of Assisted Reproduction Genetics, Human Genetics, Reproductive BioMedicine Online, Human Reproduction, and Reproductive Biology and Endocrinology and as the editor for a textbook on recurrent implantation failure. His research interests include ART laboratory science QA/QC, embryonic competence and aneuploidy, the microbiome, and nutritional status’ effect on ART success.

Read more

Formación

BS The College of William and Mary (2005)
MD The University of Virginia (2009)
Residency The University of North Carolina (2013)
Fellowship Rutgers University, Reproductive Medicine Associates of New Jersey (2016)
CREST Scholar Duke University (2017)

Honores y reconocimientos

Human Reproduction Top Reviewer

2017
British Journal of Obstetrics and Gynecology Top Reviewer

2016
Fertility and Sterility Star Reviewer Award – Dr. Anne Steiner Associate Editor

2016
Fertility and Sterility Star Reviewer Award – Dr. Carlos Simon Associate Editor

2016
Second Place Poster Presentation Award – American Society for Reproductive Medicine

2016
Society of Reproductive Biologists and Technologists (SRBT) Prize Paper Award at ASRM

2016
American Association of Bioanalysts Prize Paper Award

2016
Pacific Coast Reproductive Society Excellence in Training Paper Award

2016
American College of Surgeon’s Resident Teaching Certificate of Outstanding Merit

2013
Resident Teaching Award in OB/GYN

2013
Golden Tarheel Award for Resident Teaching

2013

Publicaciones


  • Patients with endometriosis have aneuploidy rates equivalent to their age-matched peers in the in vitro fertilization population.Juneau C, Kraus E, Werner M, Franasiak J, Morin S, Patounakis G, Molinaro T, de Ziegler D, Scott RT.
    Fertil Steril, Epub, Jun 23, 2017.

  • Characterizing the endometrial microbiome: next generation sequencing of the 16s ribosomal gene.
    Tao X, Franasiak J, Zhan Y, Rajchel J, Bedard J, Scott R, Treff N, Chu T.
    Hum Microbiome J, 3:15-21, 2017.

  • Laser acupuncture before and after embryo transfer improves in vitro fertilization outcomes: A four-armed randomized controlled trial.Morin S, Frattarelli J, Franasiak J, Juneau C, Scott RT.
    Medical Acupuncture, 29: 56-65, 2017.

  • Follicular flushing: time to look elsewhere to improve IVF outcomes?
    Franasiak J.
    British J Obstet Gynecol, 124:1197, 2017.

  • Endometrial microbiome.
    Franasiak J, Scott RT.
    Curr Opin Obstet Gynecol, 229:146-152, 2017.

  • Combination of uterine natural killer cell immunoglobulin receptor haplotype and trophoblastic HLA-C ligand influences the risk of pregnancy loss: a retrospective cohort analysis of direct embryo genotyping data from euploid transfers.
    Morin S, Treff N, Tao X, Scott RT 3rd, Franasiak J, Juneau C, Maguire M, Scott RT.
    Fertil Steril, 107:677-683, 2017.

  • High relative deoxyribonucleic acid of trophectoderm biopsy adversely affects pregnancy outcomes.
    Neal S, Franasiak J, Forman E, Werner M, Morin S, Tao X, Treff N, Scott RT.
    Fertil Steril, 107:731-736.

  • Does supplementation with progestogens in the first trimester of pregnancy prevent miscarriage in women with unexplained recurrent miscarriage?
    Saccone G, Schoen S, Franasiak J, Scott R, Berghella V.
    Fertil Steril, 107:430-438.

  • Detection of segmental aneuploidy and mosaicism in the human preimplantation embryo: technical considerations and limitations.
    Treff N, Franasiak J.
    Fertil Steril, 107:27-31.

  • Vitamin D in human reproduction-an evolving landscape.
    Franasiak J.
    Fertil Steril,106:1650-1651.

  • Embryonic aneuploidy does not differ amongst major ethnicities as determined by genotyping.
    Franasiak J, Olcha M, Treff N, Scott RT.
    Hum Reprod 31:2391-5, 2016.

  • Promoting the use of elective single embryo transfer in clinical practice.
    Tobias T, Sharara F, Franasiak J, Heiser P, Pinckney-Clark E.
    Fertility Research and Practice. Aug 2016.

  • Why abandoning sustained implantation rate may be throwing the baby out with the bathwater.
    Forman E, Franasiak J, Patounakis G, Scott R.
    Hum Reprod 31:1926-7.

  • CYP1A1 3801T>C Polymorphism implicated in altered xenobiotic metabolism is not Associated with Variations in Total Motile Sperm or Fertilization Rates with ICSI.
    Franasiak J, Barnett R, Treff N, Scott RT.
    Fertil Steril, 106:481-6, 2016.

  • Genotypically determined ancestry across an infertile population: ovarian reserve and response parameters are not influenced by continental origin.
    Olcha M, Franasiak J, Taylor D, Treff N, Scott RT.
    Fertil Steril 106:475-80, 2016.

  • Challenges facing contemporary preimplantation genetic screening.
    Juneau C, Franasiak J, Treff N.
    Curr Opin Obstet Gynecol 28:151-7, 2016.

  • FMR1 Gene CGG repeat number variation within the normal range is not predictive of ovarian response in IVF cycles.
    Morin S, Tiegs A, Franasiak J, Juneau CR, Scott RT.
    RBM Online 32:496-502, 2016.

  • Free vitamin D does not vary through the proliferative phase of the menstrual cycle.
    Franasiak J, Wang X, Sun W, Molinaro T, Green K, Werner M, Juneau C, Morin S, Scott RT.
    Endocrine 53:322-6, 2016.

  • Both slowly developing embryos and a variable pace of luteal endometrial progression may conspire to prevent a normal birth in spite of a capable embryo.
    Franasiak J, Ruiz-Alonso M, Scott RT, Simon, C.
    Fertil Steril, 105:861-6, 2016.

  • Curbside consults in the era of social media connectivity and the creation of the SREI Forum.
    Franasiak J, Ku L, Barnhart K.
    Fertil Steril 105:885-6, 2016.

  • Sequential versus Monophasic Media Impact Trial (SuMMIT): a paired randomized controlled trial comparing a sequential media system to a monophasic medium.
    Werner M, Hong K, Franasiak J, Forman E, Reda C, Molinaro T, Upham K, Scott RT.
    Fertil Steril, 105:1215-21, 2016.

  • Expanded carrier screening in an infertile population: how often is clinical decision making affected?
    Franasiak J, Olcha M, Bergh P, Hong K, Werner M, Forman E, Zimmerman R, Scott RT.
    Genetics in Medicine, 2016.

  • DHEA supplementation results in supraphysiologic DHEA-S serum levels that interfere with progesterone imm in IVF.
    Franasiak J, Werner MD, Juneau CR, Scott RT, Forman EJ.
    J Assist Reprod Genet 33:387-91, 2016.

  • Multiple thrombophilic single nucleotide polymorphisms lack a significant effect on outcomes in fresh IVF cycles: an analysis of 1717 patients.
    Patounakis G, Bergh E, Forman E, Tao X, Lonczak A, Franasiak J, Treff N, Scott RT.
    J Assist Reprod Genet 33:67-73, 2015.

  • The microbiome in human reproduction.
    Franasiak J, Scott RT.
    Fertil Steril, 104:1341-3, 2015.

  • The microbiome in assisted reproductive technologies.
    Franasiak J, Scott RT.
    Fertil Steril, 104:1364-71, 2015.

  • Endometrial Microbiome at the Time of Embryo Transfer: Next Generation Sequencing of the 16s Ribosomal Subunit.
    Franasiak J, Werner M, Juneau C, Tao X, Landis J, Zhan Y, Treff N, Scott RT.
    J Assist Reprod Genet 33:129-36, 2015.

  • Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo quality.
    Green K, Werner M, Franasiak J, Juneau CR, Hong KH, Scott RT.
    J Assist Reprod Genet 32:1469-76, 2015.

  • Ergonomic Strain in Minimally Invasive Surgery: Addressing the Strain Epidemic.
    Franasiak J, Gehrig P.
    J Clin Outcomes Management, Vol 22 (6), 2015.

  • Elevated Progesterone levels in women on DHEA supplementation likely represents assay interference.
    Forman E, Franasiak J, Scott RT.
    J Assist Reprod Genet, 32:661, 2015.

  • Endometrial disruption does not improve implantation in patients who have failed the transfer of euploid blastocysts.
    Werner M, Forman E, Hong KH, Franasiak J, Bergh PA, Scott RT.
    Fertil Steril 32:557-62, 2015.

  • Blastocyst transfer is not associated with increased rates of monozygotic twins when controlling for embryo cohort quality.
    Franasiak J, Dondik Y, Molinaro TA, Hong KH, Forman EJ, Werner MD, Upham KM, Scott RT Jr.
    Fertil Steril 103:95-100, 2015.

  • Discordant embryonic aneuploidy testing and prenatal ultrasonography prompting androgen insensitivity syndrome diagnosis.
    Franasiak J, Yao X, Ashkindaze E, Rosen T. Scott RT.
    Obstet Gynecol 125:383-6, 2015.

  • Pregnancy success after hysteroscopic sterilization reversal.
    Franasiak J, Monteith C, Berger G, Zerden M.
    Obstetrics and Gynecology 124(6):1183-9, 2014. recognized for editorial assistance.

  • Vitamin D levels do not impact IVF outcomes following the transfer of a euploid blastocyst. Reply to Letter.
    Franasiak J, Molinaro T, Scott RT.
    Am J Obstet Gynecol 212:411-2, 2014.

  • Vitamin D levels do not impact IVF outcomes following the transfer of a euploid blastocyst. Reply to Letter.
    Franasiak J, Molinaro T, Scott RT.
    Am J Obstet Gynecol 212:413, 2014.

  • Vitamin D levels do not impact IVF outcomes following the transfer of a euploid blastocyst.
    Franasiak J, Molinaro T, Dubell E, Scott K, Ruiz A, Forman EJ, Hong KH, Werner M, Scott RT.
    Am J Obstet Gynecol, 212:315.e1-6, 2014.

  • Aneuploidy across individual chromosomes at the embryonic level in trophectoderm biopsies: changes with patient age and chromosome structure.
    Franasiak J, Forman EJ, Hong KH, Werner M, Upham K, Treff NR, Scott RT.
    J Assist Reprod Genet 31:1501-9, 2014.

  • Feasibility, acceptance, and efectiveness of an ergonomics training program.
    Franasiak J, Craven R, Mosaly P, Gehrig PA.
    J Soc Laparoendosc Surg 18: e2014.00166, 2014.

  • Defining the "sweet spot" for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect against a clinically significant late follicular increase in progesterone: an analysis of 10,280 first in vitro fertilization cycles.
    Werner M, Forman E, Hong KH, Franasiak J, Molinaro T, Scott RT.
    Fertil Steril, 102:1312-7, 2014.

  • Embryonic aneuploidy: overcoming molecular genetics challenges improves outcomes and changes practice patterns.
    Franasiak J, Scott RT.
    Trends Mol Med 20:499-508, 2014.

  • Comprehensive chromosome screening (CCS) with synchronous blastocyst transfer: Time for a paradigm shift.
    Scott RT, Franasiak J, Forman E.
    Fertil Steril,102:660-1, 2014.

  • Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and macaques with endometriosis.
    Franasiak J, Burns K, Slayden O, Yuan L, Fritz M, Korach K, Lessey BA, Young SL.
    Reprod Sci 22:442-51, 2014.

  • Reply to the Authors.
    Franasiak J, Forman E, Scott RT.
    Fertil Steril, 102:e4, 2014.

  • Prospective assessment of mid-secretory endometrial LIF in women with unexplained infertility and suspected endometriosis.
    Franasiak J, Holoch KJ, Yuan L, Schammel DP, Young SL, Lessey BA.
    Fertil Steril, 101:1724-31, 2014.

  • Metformin is associated with improved survival in endometrial cancer.
    Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, Havrilesky L, Alvarez Secord A, Moore D, Gehrig P, Bae-Jump VL.
    Gynecol Oncol 133:28-32, 2014.

  • Does Lower Uterine Segment Involvement in Grade 3 Endometrial Cancer Impact Recurrence Patterns and Patient Outcomes?
    Clark L, Gehrig P, Bae-Jump VL, Franasiak J, Ko EM.
    J Clin Gynecol Obstet 3:85-92, 2014.

  • The nature of aneuploidy with increasing age of the female partner: A review of 15,169 trophectoderm biopsies undergoing comprehensive chromosomal screening.
    Franasiak J, Forman EJ, Hong KH, Werner M, Upham K, Treff NR, Scott RT.
    Fertil Steril 101:656-663.e1, 2013.

  • Obstetric and neonatal outcomes from the BEST Trial: Single embryo transfer with aneuploidy screening improves outcomes after IVF without compromising delivery rates.
    Forman EJ, Hong KH, Franasiak J, Scott RT.
    Am J Obstet Gynecol, 210:157.e1-6, 2013.

  • The complex triad of obesity, race and diabetes in Type I and Type II endometrial cancers: examining their distribution and associations with outcomes.
    Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Havrilesky L, Alvarez Secord A, Moore D, Gehrig P, Bae-Jump VL.
    Gynecol Oncol 133:28-32, 2013.

  • Ergonomic deficits in robotic gynecologic oncology surgery: A need for intervention.
    †Craven R, †Franasiak J, Mosaly P, Gehrig PA.
    J Minimal Inv Gynecol 20:648-55, 2013. †Authors contributed equally.

  • Levels and associations among self-esteem, fertility distress, coping and reaction to potentially being a genetic carrier in women with Diminished Ovarian Reserve.Cizmeli C, Lobel M, Franasiak J, Pastore LM.
    Fertil Steril, 99:2037-44.e3, 2013.

  • Fever without a source in the pregnant patient: A case report and review of the literature.
    Linthavong O, Franasiak J, Ivester T.
    Obstet Gynecol, 121:675-81, 2013.

  • Longitudinal anti-müllerian hormone in women with polycystic ovary syndrome: An acupuncture randomized clinical trial, evidence-based complementary and alternative medicine.
    Franasiak J, Young SL, Williams CD, Pastore LM.
    2012:973712, 2012.

  • Physical Strain and Urgent Need for Ergonomic Training Among Gynecologic Oncologists who Perform Minimally Invasive Surgery.
    Franasiak J, Ko E, Kidd J, Alvarez-Secord A, Bell M, Boggess J, Gehrig P.
    Gynecol Oncol, 126:437, 42, 2012.

  • Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile,
    Pawlowski SW, Archbald-Pannone L, Carman RJ, Alcantara-Warren C, Lyerly D, Genheimer CW, Gerding DN, Guerrant RL, Franasiak J acknowledged for performing experiments.
    Journal of Hospital Infection 73(2):185-7, 2009.

  • Community acquired clostridium difficile in Vhembe district, South Africa: Studies using molecular biology methods for the detection of Triose phosphate isomerase (tpi), Toxin A (tcdA), Toxin B (tcdB), Binary Toxin (cdtA, cdtB) and tcdC genes.
    Amidou S, Chikwelu O, Franasiak J, Pannone L, Pascal B, Alcantara C, Guerrant R.
    Amer J Trop Med Hyg, 78:577-85, 2008.

Read more

Presentations

Read more
Cerrar menú